The Muller lab is interested in catalytic RNA molecules (ribozymes). We focus on two areas, ribozymes in the origin of life and ribozymes as therapeutic agents. In specific, we are developing ribozymes that feature improved substrate recognition and improved reaction pathways, compared with their current 'relatives'. This is accomplished using chemical modification of RNA, rational sequence design and in vitro evolution.
